Effect of Ketoconazole on the plasma pharmacokinetics of Axitinib (AG-013736) in healthy volunteers

被引：0
|
作者：
Pithavala, Yazdi
Klamerus, Karen
Garrett, May
Hee, Brian
Mount, Janessa
Selaru, Paulina
Sarapa, Nenad
机构：
[1] Pfizer Inc, San Diego, CA USA
[2] CPCS Pharma Consulting, Morristown, NJ USA
来源：
CANCER RESEARCH | 2008年 / 68卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
232
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Effect of food on the pharmacokinetics of Axitinib (AG-013736) in healthy volunteers
    Pithavala, Yazdi
    Toh, Melvin
    Mount, Janessa
    Garrett, May
    Hee, Brian
    Selaru, Paulina
    Klamerus, Karen
    CANCER RESEARCH, 2008, 68 (09)
  • [2] Effect of Rifampin on the plasma pharmacokinetics of Axitinib (AG-013736) in Caucasian and Japanese healthy volunteers
    Pithavala, Yazdi
    Tortorici, Michael
    Toh, Melvin
    Garrett, May
    Hee, Brian
    Kuruganti, Uma
    Ni, Grace
    Klamerus, Karen
    CANCER RESEARCH, 2008, 68 (09)
  • [3] Effect of rifampin on the pharmacokinetics of Axitinib (AG-013736) in Japanese and Caucasian healthy volunteers
    Pithavala, Y. K.
    Tortorici, M.
    Toh, M.
    Garrett, M.
    Hee, B.
    Kuruganti, U.
    Ni, G.
    Klamerus, K. J.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (03) : 563 - 570
  • [4] Effect of rifampin on the pharmacokinetics of Axitinib (AG-013736) in Japanese and Caucasian healthy volunteers
    Y. K. Pithavala
    M. Tortorici
    M. Toh
    M. Garrett
    B. Hee
    U. Kuruganti
    G. Ni
    K. J. Klamerus
    Cancer Chemotherapy and Pharmacology, 2010, 65 : 563 - 570
  • [5] Effect of axitinib (AG-013736) concentration on QT interval after administration alone and in combination with ketoconazole in healthy volunteers.
    Houk, B. E.
    Sarapa, N.
    Pithavala, Y. K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S53 - S53
  • [6] An open-label phase 1 study to evaluate the pharmacokinetics of axitinib (AG-013736) in healthy Chinese volunteers
    Chen, Ying
    Jiang, Ji
    Zhang, Jianyan
    Tortorici, Michael
    Pithavala, Yazdi K.
    Lu, Lei
    Ni, Grace
    Hu, Pei
    CANCER RESEARCH, 2010, 70
  • [7] Effect of ketoconazole on the pharmacokinetics of axitinib in healthy volunteers
    Pithavala, Yazdi K.
    Tong, Warren
    Mount, Janessa
    Rahavendran, Sadayappan V.
    Garrett, May
    Hee, Brian
    Selaru, Paulina
    Sarapa, Nenad
    Klamerus, Karen J.
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (01) : 273 - 281
  • [8] Effect of ketoconazole on the pharmacokinetics of axitinib in healthy volunteers
    Yazdi K. Pithavala
    Warren Tong
    Janessa Mount
    Sadayappan V. Rahavendran
    May Garrett
    Brian Hee
    Paulina Selaru
    Nenad Sarapa
    Karen J. Klamerus
    Investigational New Drugs, 2012, 30 : 273 - 281
  • [9] INFLUENCE OF SELECTED DEMOGRAPHIC AND CLINICAL FACTORS ON THE PHARMACOKINETICS (PK) AND EFFICACY OF AXITINIB (AG-013736; AG) IN HEALTHY VOLUNTEERS (HVS) AND METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS
    Garrett, M.
    Pithavala, Y. K.
    Rini, B. I.
    Rixe, O.
    Bukowski, R. M.
    Kim, S.
    Amantea, M. A.
    Houk, B. E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S43 - S43
  • [10] COMPARISON OF AXITINIB ( AG-013736; AG) PHARMACOKINETICS ( PK) IN HEALTHY VOLUNTEERS ( HVS; RICH DATA) AND PATIENTS ( PTS; SPARSE DATA) USING POPULATION PK ANALYSIS.
    Tortorici, M. A.
    Fruehauf, J. P.
    Schiller, J. H.
    Cohen, E. E.
    Niethammer, A.
    Pithavala, Y. K.
    Garrett, M.
    Ruiz-Garcia, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S75 - S75
12345